Special Issue "Marine Compounds and Their Application in Neurological Disorders"
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 January 2016)
Prof. Dr. George Perry
College of Sciences, University of Texas at San Antonio, San Antonio, Texas 79249-0661, USA
Website | E-Mail
Fax: +1 210 458 4445
Interests: mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease; the mechanism for RNA-based redox metal binding; the consequences of RNA oxidation on protein synthesis rate and fidelity; the role of redox active metals in mediating prooxidant and antioxidant properties; the signal transduction pathways altered in Alzheimer disease that allow neurons to evade apoptosis; mechanism of phosphorylation control of oxidative damage to neurofilament proteins
Neurological disorders such as Alzheimer's disease and Parkinson's disease have become one of the greatest threats to public health. We are constantly searching for new drugs to treat these diseases. The marine environment is a rich source of chemical structures with significant biological activities. Several marine-derived compounds have shown potential in the treatment of neurological disorders. The Special Issue "Marine Compounds and Its Application in Neurological Disorders" aims to present recent advances in the discovery and development of marine natural products, which can affect the nervous system or have therapeutic potential. As a guest editor, I invite you to submit review papers or original articles to this special issue.
Prof. Dr. George Perry
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Alzheimer's disease
- Parkinson's disease
- oxidative stress